Inicio Área de profesionales Artículos publicados Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: analysis of biological markers in a GEICAM phase II study

Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: analysis of biological markers in a GEICAM phase II study

Correo electrónico Imprimir

G Estévez L, Fortes JL, Adrover E, Peiró G, Margel M, Castellá E, Cuevas JM, Bernet L, Seguí MA, Andreu X. Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: analysis of biological markers in a GEICAM phase II study. Clinical & Translational Oncology 2009; 11(1):54-59

Para más información vaya al siguiente enlace:

http://www.springerlink.com/content/g061232522kn5341/